Covid-19: India dispatches Covishield vaccines to Bahrain, Sri Lanka

India's Ministry of External Affairs had announced vaccine rollout for several countries from January 20

Coronavirus vaccine, Covishield, Covaxin
Special Freezer truck for Covid Vaccine transportation, in New Delhi.
ANI Asia
1 min read Last Updated : Jan 28 2021 | 9:38 AM IST

After providing coronavirus vaccines to several countries including Bangladesh, Nepal and Maldives, India on Thursday established its position as a reliable partner in COVID-19 assistance by dispatching Covishield vaccines to Bahrain and Sri Lanka.

A consignment of 50,400 doses of coronavirus vaccines will be provided by India to Sri Lanka under the Vaccine Maitri initiative, while Bahrain will receive get 10,800 doses.

The Covishield vaccine developed by Serum Institute of India (SII) was loaded to the cargo aircraft at Mumbai and left as per schedule at 7:55 am for Manama.

The vaccine consignment for Colombo was delayed for 15 minutes and is scheduled to leave at 9:00 am.

Bahrain had earlier approved Covishield to support its efforts towards vaccinating members at risk of developing complications from COVID-19.

Meanwhile, India has supplied COVID-19 vaccines to neighbouring countries including Bhutan, Maldives, Nepal, Myanmar, Sri Lanka, Afghanistan and Bangladesh under Neighbourhood First policy.

India's Ministry of External Affairs on Tuesday had announced vaccine rollout for several countries from January 20.

India sees international cooperation in the area of fight against COVID-19 pandemic as its duty; New Delhi has played the role of the first responder in the region.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineSerum Institute of Indiasri lanka

First Published: Jan 28 2021 | 9:32 AM IST

Next Story